STS and breast carcinoma: We present here theadvances achieved in the development of newsulfamoylated 4-(1-phenyl-1H-1,2,3-triazol-4-yl)phenolderivatives as potent steroid sulfatase (STS) inhibitors for the treatmentof breast cancer.